Bases bibliographiques Pascal et Francis

Aide

Résultats de votre recherche

Votre recherche

ct.\*:("Anticancéreux")

Filtre

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Type de document [dt]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Année de publication [py]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Discipline (document) [di]

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Langue

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Pays auteur

A-Z Z-A Fréquence ↓ Fréquence ↑
Export CSV

Résultats 1 à 25 sur 122440

  • Page / 4898
Export

Sélection :

  • et

CTLA4 Blockade Broadens the Peripheral T-Cell Receptor RepertoireROBERT, Lidia; TSOI, Jennifer; KOYA, Richard C et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2424-2432, issn 1078-0432, 9 p.Article

Dose Selection, Pharmacokinetics, and Pharmacodynamics of BRAF Inhibitor Dabrafenib (GSK2118436)FALCHOOK, Gerald S; LONG, Georgina V; CHIN, Melvin T et al.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4449-4458, issn 1078-0432, 10 p.Article

How do the EMA and FDA decide which anticancer drugs make it to the market? A comparative qualitative study on decision makers' viewsTAFURI, G; STOLK, P; TROTTA, F et al.Annals of oncology. 2014, Vol 25, Num 1, pp 265-269, issn 0923-7534, 5 p.Article

Importance of EGFR/ERCC1 Interaction Following Radiation-Induced DNA DamageLICCARDI, Gianmaria; HARTLEY, John A; HOCHHAUSER, Daniel et al.Clinical cancer research (Print). 2014, Vol 20, Num 13, pp 3496-3506, issn 1078-0432, 11 p.Article

Molecular Pathways: Turning Proteasomal Protein Degradation into a Unique Treatment ApproachSTINTZING, Sebastian; LENZ, Heinz-Josef.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3064-3070, issn 1078-0432, 7 p.Article

Mouse pharmacokinetics and metabolism of the curcumin analog, 4-piperidinone,3,5-bis[(2-fluorophenyl)methylene]-acetate(3E,5E) (EF-24; NSC 716993)REID, Joel M; BUHROW, Sarah A; GILBERT, Judith A et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1137-1146, issn 0344-5704, 10 p.Article

P-Glycoprotein, CYP3A, and Plasma Carboxylesterase Determine Brain and Blood Disposition of the mTOR Inhibitor Everolimus (Afinitor) in MiceSENG CHUAN TANG; SPARIDANS, Rolf W; KA LEI CHEUNG et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3133-3145, issn 1078-0432, 13 p.Article

Pharmacokinetics and safety of cetuximab in a patient with renal dysfunctionKRENS, L. L; BAAS, J. M; VERBOOM, M. C et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1303-1306, issn 0344-5704, 4 p.Article

Pharmacokinetics of liposomal-encapsulated and un-encapsulated vincristine after injection of liposomal vincristine sulfate in beagle dogsJIE ZHONG; WENXUE MAO; RONG SHI et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 3, pp 459-466, issn 0344-5704, 8 p.Article

Presence of Somatic Mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in Cisplatin-Resistant Germ Cell TumorsFELDMAN, Darren R; IYER, Gopa; VAN ALSTINE, Lindsay et al.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3712-3720, issn 1078-0432, 9 p.Article

Rational Combination Therapy of Vintafolide (EC145) with Commonly Used Chemotherapeutic DrugsREDDY, Joseph A; DORTON, Ryan; BLOOMFIELD, Alicia et al.Clinical cancer research (Print). 2014, Vol 20, Num 8, pp 2104-2114, issn 1078-0432, 11 p.Article

Seeing the Forest for the Trees: Kidney Oncogenomes in Relation to Therapeutic OutcomesCHISM, David D; RATHMELL, W. Kimryn.Clinical cancer research (Print). 2014, Vol 20, Num 7, pp 1721-1723, issn 1078-0432, 3 p.Article

Targeting Cancer Cells via the Reactive Oxygen Species-Mediated Unfolded Protein Response with a Novel Synthetic Polyphenol ConjugateSOON YOUNG SHIN; JONG MIN LEE; MI SO LEE et al.Clinical cancer research (Print). 2014, Vol 20, Num 16, pp 4302-4313, issn 1078-0432, 12 p.Article

Improving chemoradiation efficacy by PI3-K/AKT inhibitionSTEGEMAN, Hanneke; SPAN, Paul N; KAANDERS, Johannes H. A. M et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1182-1191, issn 0305-7372, 10 p.Article

Advances in Nutrition and CancerZAPPIA, Vincenzo; PANICO, Salvatore; RUSSO, Gian Luigi et al.Cancer treatment and research. 2014, Vol 159, issn 0927-3042, 458 p.Conference Proceedings

A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET PlatformDE GRAAN, Anne-Joy M; ELENS, Laure; VERWEIJ, Jaap et al.Clinical cancer research (Print). 2013, Vol 19, Num 18, pp 5210-5217, issn 1078-0432, 8 p.Article

A Proposal Regarding Reporting of In Vitro Testing ResultsSMITH, Malcolm A; HOUGHTON, Peter.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 2828-2833, issn 1078-0432, 6 p.Article

Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratioJUN CHEN; HU, Rong-Rong; YANG, Xi-Xiong et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 4, pp 925-929, issn 0344-5704, 5 p.Article

BMS-936564/MDX-1338: A Fully Human Anti-CXCR4 Antibody Induces Apoptosis In Vitro and Shows Antitumor Activity In Vivo in Hematologic MalignanciesKUHNE, Michelle R; MULVEY, Tanya; COHEN, Lewis J et al.Clinical cancer research (Print). 2013, Vol 19, Num 2, pp 357-366, issn 1078-0432, 10 p.Article

Cell Trafficking of Endothelial Progenitor Cells in Tumor ProgressionDE LA PUENTE, Pilar; MUZ, Barbara; AZAB, Feda et al.Clinical cancer research (Print). 2013, Vol 19, Num 13, pp 3360-3368, issn 1078-0432, 9 p.Article

Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapyMAUGERI-SACCA, M; BARTUCCI, M; DE MARIA, R et al.Cancer treatment reviews. 2013, Vol 39, Num 5, pp 525-533, issn 0305-7372, 9 p.Article

Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycleCHEN, J. H; CHEN, W. P; CHAN, S et al.Annals of oncology. 2013, Vol 24, Num 9, pp 2329-2335, issn 0923-7534, 7 p.Article

Determination of In Vivo Behavior of Mitomycin C-Loaded O/W Soybean Oil Microemulsion and Mitomycin C Solution Via Gamma Camera ImagingKOTMAKCI, Mustafa; KANTARCI, Gülten; ASIKOGLU, Makbule et al.Cancer biotherapy & radiopharmaceuticals. 2013, Vol 28, Num 7, pp 530-533, issn 1084-9785, 4 p.Article

Developing Safety Criteria for Introducing New Agents into Neoadjuvant TrialsDEMICHELE, Angela; BERRY, Donald A; BENZ, Chris et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 2817-2823, issn 1078-0432, 7 p.Article

Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort studyYUN, Y. H; LEE, M. K; HEO, D. S et al.Annals of oncology. 2013, Vol 24, Num 2, pp 489-494, issn 0923-7534, 6 p.Article

  • Page / 4898